bluebird bio Inc (BLUE)
0.348
+0.05
(+16.82%)
USD |
NASDAQ |
Nov 22, 16:00
0.34
-0.01
(-2.30%)
After-Hours: 20:00
bluebird bio Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 27, 2024 | 1.846 |
| September 26, 2024 | 1.821 |
| September 25, 2024 | 1.750 |
| September 24, 2024 | 1.83 |
| September 23, 2024 | 1.789 |
| September 20, 2024 | 1.721 |
| September 19, 2024 | 1.801 |
| September 18, 2024 | 1.812 |
| September 17, 2024 | 1.830 |
| September 16, 2024 | 2.114 |
| September 13, 2024 | 2.217 |
| September 12, 2024 | 2.101 |
| September 11, 2024 | 2.129 |
| September 10, 2024 | 2.088 |
| September 09, 2024 | 1.970 |
| September 06, 2024 | 1.935 |
| September 05, 2024 | 2.081 |
| September 04, 2024 | 2.050 |
| September 03, 2024 | 2.076 |
| August 30, 2024 | 2.054 |
| August 29, 2024 | 2.168 |
| August 28, 2024 | 2.281 |
| August 27, 2024 | 2.306 |
| August 26, 2024 | 2.563 |
| August 23, 2024 | 2.520 |
| Date | Value |
|---|---|
| August 22, 2024 | 2.477 |
| August 21, 2024 | 2.625 |
| August 20, 2024 | 2.423 |
| August 19, 2024 | 2.532 |
| August 16, 2024 | 2.595 |
| August 15, 2024 | 2.581 |
| August 14, 2024 | 2.982 |
| August 13, 2024 | 3.878 |
| August 12, 2024 | 3.599 |
| August 09, 2024 | 3.644 |
| August 08, 2024 | 3.696 |
| August 07, 2024 | 3.450 |
| August 06, 2024 | 3.732 |
| August 05, 2024 | 3.622 |
| August 02, 2024 | 4.062 |
| August 01, 2024 | 3.952 |
| July 31, 2024 | 4.244 |
| July 30, 2024 | 4.135 |
| July 29, 2024 | 4.464 |
| July 26, 2024 | 4.464 |
| July 25, 2024 | 4.391 |
| July 24, 2024 | 4.208 |
| July 23, 2024 | 4.537 |
| July 22, 2024 | 4.171 |
| July 19, 2024 | 3.842 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5576
Minimum
Nov 08 2021
5.074
Maximum
Jan 12 2023
1.606
Average
1.291
Median
Price to Book Value Benchmarks
| AIM ImmunoTech Inc | 4.594 |
| Perspective Therapeutics Inc | 0.7181 |
| Protalix BioTherapeutics Inc | 3.859 |
| Electromed Inc | 6.049 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 1.145 |
| PEG Ratio | -0.0016 |
| Price | 0.348 |
| Earnings Yield | -514.4% |
| Market Cap | 67.67M |
| PEGY Ratio | -0.0016 |